Amir Nashat

CIK: 0001575843

Transaction Breakdown

Open Market Buys (P)3 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)4 (44.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAMP

Camp4 Therapeutics Corp

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CAMP
Camp4 Therapeutics Corp
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
CAMP
Camp4 Therapeutics Corp
Sep 11, 2025
Purchase(P)
Indirect
1.2M shares at avg. $1.53$1.9M
CAMP
Camp4 Therapeutics Corp
Sep 11, 2025
Purchase(P)
Indirect
85.5K shares at avg. $1.53$131K
CAMP
Camp4 Therapeutics Corp
Jun 25, 2025
Award(A)
Stock Option (Right to Buy)
Direct
9K shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
1.3M shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Purchase(P)
Indirect
909.1K shares at avg. $11.00$10.0M
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
87.4K shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
353.7K shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Indirect
24.7K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Sep 11, 2025	CAMP Camp4 Therapeutics Corp	Purchase(P)	1,221,721	$1.53	$1,869,233	Indirect
Sep 11, 2025	CAMP Camp4 Therapeutics Corp	Purchase(P)	85,468	$1.53	$130,766	Indirect
Jun 25, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	9,000	-	-	Direct
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	1,250,061	-	$0	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Purchase(P)	909,090	$11.00	$9,999,990	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	87,448	-	$0	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	353,718	-	$0	Indirect
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	24,745	-	$0	Indirect

1-9 of 9 transactions

About Nashat Amir

Nashat Amir (SEC CIK 0001575843) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP).

Signal8 holds 5 ownership filings by Nashat Amir (1 Form 3, 4 Form 4), filed between Oct 10, 2024 and Jun 12, 2026. Those filings report 9 transactions, from Oct 15, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nashat Amir's filings is in BOSTON, MA.

Recent filings by Nashat Amir

Jun 10, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
Sep 11, 2025: Open-market purchases of CAMP shares (2 lines, Form 4, code P).
Jun 25, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
Oct 15, 2024: Conversion of CAMP shares (Form 4, code C).
Oct 15, 2024: Open-market purchase of CAMP shares (Form 4, code P).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
5AM Partners VI, LLC, 10% Owner
Young Richard A, Director
Maricich Yuri, Chief Medical Officer

How to read Form 4 transaction codes